Natasha Persaud

In a study, diabetes increased the odds of pathologic upgrading of renal cell carcinoma by 65% and 32%, among patients undergoing partial and radical nephrectomy, respectively.

Investigators compared androgen deprivation therapy plus abiraterone or docetaxel with androgen deprivation therapy alone.

Clinicians should closely monitor patients’ blood pressure after nephrectomy, according to investigators.

Research documents both direct and indirect effects of the COVID-19 pandemic on kidney health.

Whether the center was an academic setting or not had no bearing on results.

Physicians need to learn how to address financial toxicity in clinical practice, according to investigators.

The risk for hyperkalemia was highest with use of steroidal MRAs in combination with other RAASi.

Study findings support vaginal estrogen as prophylactic therapy for women with recurrent urinary tract infection.

Latest findings are from a study of 36,756 men with universal access to PSA screening.

Histologic lesions in the kidney may reflect systemic processes that lead to cardiovascular events, according to investigators.

The ratio is a clinically meaningful indicator that is easily obtained from blood test results, according to investigators.

The slow clinical adoption of sodium-glucose cotransporter-2 inhibitors may partly be due to concerns about potential adverse effects, investigators suggested.

SGLT2 inhibitors and MRAs might provide complementary effects for organ protection, according to investigators.

Foot radiography and serum markers may be effective screening tools for early prevention and therapy.

Investigators reported findings from the GÖTEBORG-2, a large, population-based randomized screening trial.

The effects of combined verinurad and febuxostat treatment were independent of blood pressure.

Among other causes, dapagliflozin treatment reduced the rate of hospitalization due to cancer.

Statin use in prostate cancer is attractive given their proven cardiovascular benefits and favorable toxicity profile, according to investigators.

Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.

Investigators examined the trajectory of nutrition parameters in patients on hemodialysis by degree of hyperparathyroidism.

Although the risks of developing a second primary cancer after radiation therapy were relatively small, they increased over time.

Coronary calcification developed with poorly controlled tertiary hyperparathyroidism and elevated iFGF23 levels after transplantation, the investigators reported.

A retrospective case-control study indicates that parathyroidectomy improves patient-level outcomes.

A round up of studies suggests it is difficult to increase serum total 25-hydroxyvitamin D levels enough to effectively lower elevated parathyroid hormone (PTH) levels in overweight patients with chronic kidney disease.

Sugar-sweetened beverages are a frequently consumed ultra-processed food group.

Investigators focused on the prognostic value of the uremic solutes asymmetric dimethylarginine, symmetric dimethylarginine, and trimethylamine-N-oxide.

Use of home dialysis and modalities other than conventional in-center hemodialysis is expected to grow.

Providers need to assess the benefit-risk profile of SGLT2 inhibitors for individual patients, and take steps to avoid unnecessary risks.

Switching from oral to intravenous calcimimetic may lower PTH levels in patients on hemodialysis with poor tolerance.

Even occasional physical activity was linked to a decreased risk for death from any cause, investigators reported.